Witnessing the stock’s movement on the chart, on Wednesday, BeOne Medicines Ltd ADR (NASDAQ: ONC) set off with pace as it heaved 4.22% to $333.87, before settling in for the price of $320.35 at the close. Taking a more long-term approach, ONC posted a 52-week range of $172.67-$385.22.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 17.28%. Meanwhile, its Annual Earning per share during the time was 17.28%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 147.64%. This publicly-traded company’s shares outstanding now amounts to $110.62 million, simultaneously with a float of $110.11 million. The organization now has a market capitalization sitting at $36.93 billion. At the time of writing, stock’s 50-day Moving Average stood at $326.99, while the 200-day Moving Average is $292.15.
BeOne Medicines Ltd ADR (ONC) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. BeOne Medicines Ltd ADR’s current insider ownership accounts for 0.46%, in contrast to 29.66% institutional ownership. According to the most recent insider trade that took place on Dec 15 ’25, this organization’s Chief Executive Officer sold 75,631 shares at the rate of 307.79, making the entire transaction reach 23,278,679 in total value, affecting insider ownership by 24,369. Preceding that transaction, on Dec 16 ’25, Company’s Chief Executive Officer sold 24,369 for 302.87, making the whole transaction’s value amount to 7,380,739. This particular insider is now the holder of 0 in total.
BeOne Medicines Ltd ADR (NASDAQ: ONC) Trading Performance Indicators
Let’s observe the current performance indicators for BeOne Medicines Ltd ADR (ONC). It’s Quick Ratio in the last reported quarter now stands at 2.17. Alongside those numbers, its PE Ratio stands at $642.30, and its Beta score is 0.52. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 7.42. Similarly, its price to free cash flow for trailing twelve months is now 67.68.
In the same vein, ONC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.52, a figure that is expected to reach 1.49 in the next quarter, and analysts are predicting that it will be 6.48 at the market close of one year from today.
Technical Analysis of BeOne Medicines Ltd ADR (ONC)
Going through the that latest performance of [BeOne Medicines Ltd ADR, ONC]. Its last 5-days volume of 0.31 million was inferior to the volume of 0.34 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 78.05% While, its Average True Range was 70.46.
Raw Stochastic average of BeOne Medicines Ltd ADR (ONC) in the period of the previous 100 days is set at 42.94%, which indicates a major fall in contrast to 95.64% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 6.91 that was lower than 9.14 volatility it exhibited in the past 100-days period.
